Found in 1989, Synmax is a leading technology company focused on developing cost-effective intermediates for the pharmaceutical market as well as specialty chemicals for the electronics industry. Relying on our synthesis and bioconversion platform, Synmax offers a broad range of products and services.While maintaining our production of 7-ADCA, an intermediate for the cephalosporin antibiotics, we have developed a new series of intermediates for cardiovascular drugs using bioprocess. Relying on our enzymatic platform we hope for further develop other products as well. On electronics front, we have successfully developed var